Leading Oncology Country Markets Databank

Leading Oncology Country Markets Databank

The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $94,840.8 Million in 2020, and is anticipated to reach $162,447.5 Million by 2029, registering a CAGR of 6.20%. Asia-Pacific and Europe collectively expected to account for about 64.7% share of the Oncology market in 2020, with the former constituting around 34.4% share. Asia-Pacific and Europe are expected to witness significant growth rates at a CAGR of 6.20% and 3.32% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 64.7% in the overall Oncology market in 2020, and is anticipated to reach 68.5% by 2029.

The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.


1. GLOBAL ONCOLOGY MARKET, BY REGION
1.1. OVERVIEW
1.2. NORTH AMERICA
1.2.1 NORTH AMERICA ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
1.2.2 NORTH AMERICA ONCOLOGY MARKET, BY CANCER TYPE
1.2.3 NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY
1.2.3.1 U.S.
1.2.3.1.1 U.S. Oncology Market, By By Cancer Diagnostics & Treatment
1.2.3.1.2 U.S. Oncology Market, By Cancer Type
1.2.3.2 Canada
1.2.3.2.1 Canada Oncology Market, By By Cancer Diagnostics & Treatment
1.2.3.2.2 Canada Oncology Market, By Cancer Type
1.2.3.3 Mexico
1.2.3.3.1 Mexico Oncology Market, By By Cancer Diagnostics & Treatment
1.2.3.3.2 Mexico Oncology Market, By Cancer Type
1.3. EUROPE
1.3.1 EUROPE ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
1.3.2 EUROPE ONCOLOGY MARKET, BY CANCER TYPE
1.3.3 EUROPE ONCOLOGY MARKET, BY COUNTRY
1.3.3.1 Germany
1.3.3.1.1 Germany Oncology Market, By By Cancer Diagnostics & Treatment
1.3.3.1.2 Germany Oncology Market, By Cancer Type
1.3.3.2 France
1.3.3.2.1 France Oncology Market, By By Cancer Diagnostics & Treatment
1.3.3.2.2 France Oncology Market, By Cancer Type
1.3.3.3 UK
1.3.3.3.1 UK Oncology Market, By By Cancer Diagnostics & Treatment
1.3.3.3.2 UK Oncology Market, By Cancer Type
1.3.3.4 Italy
1.3.3.4.1 Italy Oncology Market, By By Cancer Diagnostics & Treatment
1.3.3.4.2 Italy Oncology Market, By Cancer Type
1.3.3.5 Spain
1.3.3.5.1 Spain Oncology Market, By By Cancer Diagnostics & Treatment
1.3.3.5.2 Spain Oncology Market, By Cancer Type
1.3.3.6 Rest of Europe
1.3.3.6.1 Rest of Europe Oncology Market, By By Cancer Diagnostics & Treatment
1.3.3.6.2 Rest of Europe Oncology Market, By Cancer Type
1.4. ASIA-PACIFIC
1.4.1 ASIA-PACIFIC ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
1.4.2 ASIA-PACIFIC ONCOLOGY MARKET, BY CANCER TYPE
1.4.3 ASIA-PACIFIC ONCOLOGY MARKET, BY COUNTRY
1.4.3.1 China
1.4.3.1.1 China Oncology Market, By By Cancer Diagnostics & Treatment
1.4.3.1.2 China Oncology Market, By Cancer Type
1.4.3.2 India
1.4.3.2.1 India Oncology Market, By By Cancer Diagnostics & Treatment
1.4.3.2.2 India Oncology Market, By Cancer Type
1.4.3.3 Japan
1.4.3.3.1 Japan Oncology Market, By By Cancer Diagnostics & Treatment
1.4.3.3.2 Japan Oncology Market, By Cancer Type
1.4.3.4 Australia
1.4.3.4.1 Australia Oncology Market, By By Cancer Diagnostics & Treatment
1.4.3.4.2 Australia Oncology Market, By Cancer Type
1.4.3.5 South Korea
1.4.3.5.1 South Korea Oncology Market, By By Cancer Diagnostics & Treatment
1.4.3.5.2 South Korea Oncology Market, By Cancer Type
1.4.3.6 Rest of Asia
1.4.3.6.1 Rest of Asia Oncology Market, By By Cancer Diagnostics & Treatment
1.4.3.6.2 Rest of Asia Oncology Market, By Cancer Type
1.5. REST OF WORLD
1.5.1 REST OF WORLD ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
1.5.2 REST OF WORLD ONCOLOGY MARKET, BY CANCER TYPE
1.5.3 REST OF WORLD ONCOLOGY MARKET, BY COUNTRY
1.5.3.1 Brazil
1.5.3.1.1 Brazil Oncology Market, By By Cancer Diagnostics & Treatment
1.5.3.1.2 Brazil Oncology Market, By Cancer Type
1.5.3.2 South Africa
1.5.3.2.1 South Africa Oncology Market, By By Cancer Diagnostics & Treatment
1.5.3.2.2 South Africa Oncology Market, By Cancer Type
1.5.3.3 GCC
1.5.3.3.1 GCC Oncology Market, By By Cancer Diagnostics & Treatment
1.5.3.3.2 GCC Oncology Market, By Cancer Type
1.5.3.4 RoW Countries
1.5.3.4.1 RoW Countries Oncology Market, By By Cancer Diagnostics & Treatment
1.5.3.4.2 RoW Countries Oncology Market, By Cancer Type
TABLE 1. GLOBAL ONCOLOGY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 2. NORTH AMERICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 3. NORTH AMERICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 4. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 5. U.S. ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 6. U.S. ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 7. CANADA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 8. CANADA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 9. MEXICO ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 10. MEXICO ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 11. EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 12. EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 13. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 14. GERMANY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 15. GERMANY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 16. FRANCE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 17. FRANCE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 18. UK ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 19. UK ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 20. ITALY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 21. ITALY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 22. SPAIN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 23. SPAIN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 24. REST OF EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 25. REST OF EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 26. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 27. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 28. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 29. CHINA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 30. CHINA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 31. INDIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 32. INDIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 33. JAPAN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 34. JAPAN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 35. AUSTRALIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 36. AUSTRALIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 37. SOUTH KOREA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 38. SOUTH KOREA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 39. REST OF ASIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 40. REST OF ASIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 41. REST OF WORLD ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 42. REST OF WORLD ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 43. REST OF WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 44. BRAZIL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 45. BRAZIL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 46. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 47. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 48. GCC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
TABLE 49. GCC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
TABLE 50. ROW COUNTRIES ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 1. GLOBAL ONCOLOGY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 2. NORTH AMERICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 3. NORTH AMERICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 4. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 5. U.S. ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 6. U.S. ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 7. CANADA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 8. CANADA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 9. MEXICO ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 10. MEXICO ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 11. EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 12. EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 13. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 14. GERMANY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 15. GERMANY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 16. FRANCE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 17. FRANCE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 18. UK ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 19. UK ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 20. ITALY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 21. ITALY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 22. SPAIN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 23. SPAIN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 24. REST OF EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 25. REST OF EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 26. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 27. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 28. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 29. CHINA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 30. CHINA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 31. INDIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 32. INDIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 33. JAPAN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 34. JAPAN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 35. AUSTRALIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 36. AUSTRALIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 37. SOUTH KOREA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 38. SOUTH KOREA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 39. REST OF ASIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 40. REST OF ASIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 41. REST OF WORLD ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 42. REST OF WORLD ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 43. REST OF WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 44. BRAZIL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 45. BRAZIL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 46. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 47. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 48. GCC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
FIGURE 49. GCC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
FIGURE 50. ROW COUNTRIES ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings